Default company panoramic image
09f3e680 2e6a 4ea5 9b12 c192617f9e78

Fervent Pharmaceuticals LLC

Fervent Pharmaceuticals is a drug development company focused on re-purposing pharmaceutical agents for unmet needs in women's health.

  • Stage Product In Development
  • Industry Healthcare Services
  • Location Greenville, NC, USA
  • Currency USD
  • Founded November 2011
  • Employees 2
  • Website

Company Summary

Fervent Pharmaceuticals, LLC was formed to develop and commercialize its lead compound, FP-101, for the treatment of vasomotor symptoms associated with menopause (hot flashes) in women. This indication represents an unmet medical need in a very large, but unsatisfied market.


  • Default avatar
    George Royster

    As chairman and founder of Fervent Pharmaceuticals, George Royster is responsible for overseeing and guiding the strategic direction of the company. He currently holds a patent pending for an innovative drug in the treatment of hot flashes. Prior to starting Fervent Pharmaceuticals, Mr. Royster spent over 20 years in the healthcare a management and operations consultant.

  • Default avatar
    Michael J McKenna

    Dr. McKenna has over 30 years of industry experience in research and development, executive management, and as an advisor to companies and investment firms in the life sciences sector. Previous experience includes: founder and CEO of Merrion Pharmaceuticals, VP of science and technology at Pappas Ventures and VP of drug development at Parke Davis (Pfizer).